Advertisement

History of Drug-Coated Balloons

  • Dario Buccheri
  • Bernardo Cortese
Chapter

Abstract

The advent of balloon angioplasty (BA) for the treatment of coronary artery disease was performed by Andreas Grüntzig in 1977 [1] (Fig. 1.1) and represented a breakthrough in the field of cardiology: by that time, we can say that modern interventional cardiology was born.

References

  1. 1.
    Gruntzig A. Transluminal dilatation of coronary-artery stenosis. Lancet. 1978;311:263.CrossRefGoogle Scholar
  2. 2.
    Byrne RA, Joner M, Kastrati A. Stent thrombosis and restenosis: what have we learned and where are we going? The Andreas Grüntzig Lecture ESC 2014. Eur Heart J. 2015;36:3320–31.CrossRefGoogle Scholar
  3. 3.
    Buccheri D, Piraino D, Andolina G, Cortese B. Understanding and managing in-stent restenosis: a review of clinical data, from pathogenesis to treatment. J Thorac Dis. 2016;8:E1150–62.CrossRefGoogle Scholar
  4. 4.
    Authors/Task Force members, Windecker S, Kolh P, et al. 2014 ESC/EACTS guidelines on myocardial revascularization: the task force on myocardial revascularization of the European association for cardio-thoracic surgery (EACTS) developed with the special contribution of the European association of percutaneous cardiovascular interventions (EAPCI). Eur Heart J. 2014;35:2541–619.CrossRefGoogle Scholar
  5. 5.
    Axel DI, Kunert W, Göggelmann C, Oberhoff M, Herdeg C, Küttner A, Wild DH, Brehm BR, Riessen R, Köveker G, Karsch KR. Paclitaxel inhibits arterial smooth muscle cell proliferation and migration in vitro and in vivo using local drug delivery. Circulation. 1997;96:636–45.CrossRefGoogle Scholar
  6. 6.
    Scheller B, Speck U, Schmitt A, et al. Addition of paclitaxel to contrast media prevents restenosis after coronary stent implantation. J Am Coll Cardiol. 2003;42:1415–20.CrossRefGoogle Scholar
  7. 7.
    Scheller B, Speck U, Abramjuk C, et al. Paclitaxel balloon coating – a novel method for prevention and therapy of restenosis. Circulation. 2004;110:810–4.CrossRefGoogle Scholar
  8. 8.
    Scheller B, Hehrlein C, Bocksch W, et al. Treatment of in-stent restenosis with a paclitaxel coated balloon catheter. N Engl J Med. 2006;355:2113–24.CrossRefGoogle Scholar
  9. 9.
    Speck U, Scheller B, Abramjuk C, et al. Neointima inhibition: comparison of effectiveness of non-stent-based local drug delivery and a drug eluting stent in porcine coronary arteries. Radiology. 2006;240:411–18.17.CrossRefGoogle Scholar
  10. 10.
    Scheller B, Speck U, Romeike B, et al. Contrast media as a carrier for local drug delivery: successful inhibition of neointimal proliferation in the porcine coronary stent model. Eur Heart J. 2003;24:1462–7.CrossRefGoogle Scholar
  11. 11.
    Albrecht T, Speck U, Baier C, et al. Reduction of stenosis due to intimal hyperplasia after stent supported angioplasty of peripheral arteries by local administration of paclitaxel in swine. Invest Radiol. 2007;42:579–8.CrossRefGoogle Scholar
  12. 12.
    Tepe G, Zeller T, Albrecht T, et al. Local delivery of paclitaxel to inhibit restenosis during angioplasty of the leg. N Engl J Med. 2008;358:689–99.CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  • Dario Buccheri
    • 1
  • Bernardo Cortese
    • 2
  1. 1.Interventional CardiologyTrapani HospitalTrapaniItaly
  2. 2.Cardiac DepartmentSan Carlo ClinicMilanoItaly

Personalised recommendations